In addition to several QTL studies, we also performed differential abundance analysis to identify proteomic profiles not only for sporadic AD, but also for genetically defined AD subtypes (carriers for TREM2 risk variants and autosomal dominant AD individuals) in Knight-ADRC data. This evidence concerns the gene TREM2 and Alzheimer disease.